1416776-21-0

Basic information

• Product Name: 4-(3-Bromophenyl)-N,N-dimethylmorpholine-2-carboxamide
• Synonyms: 4-(3-Bromophenyl)-N,N-dimethylmorpholine-2-carboxamide
• CAS NO: 1416776-21-0
• Molecular Weight: 313.194
• Mol File: 1416776-21-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(3-Bromophenyl)-N,N-dimethylmorpholine-2-carboxamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(3-Bromophenyl)-N,N-dimethylmorpholine-2-carboxamide(1416776-21-0)
• EPA Substance Registry System: 4-(3-Bromophenyl)-N,N-dimethylmorpholine-2-carboxamide(1416776-21-0)

Safety Data

• Hazardous Substances Data: 1416776-21-0(Hazardous Substances Data)

Upstream product

• 108-36-1 1,3-dibromobenzene 
• 135072-23-0 N,N-dimethylmorpholine-2-carboxamide 
• 135072-18-3 4-benzyl-N,N-dimethylmorpholine-2-carboxamide 
• 135072-15-0 4-benzylmorpholine-2-carboxylic acid hydrochloride 

Downstream Products

• 1416776-23-2 tert-Butyl (1-{4-[2-(2-aminopyridin-3-yl)-5-{3-[2-(dimethylcarbamoyl) morpholin-4-yl]phenyl}-3H-imidazo[4,5-b]pyridin-3-yl]phenyl}cyclobutyl)carbamate 
• 1416776-22-1 N,N-dimethyl-4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]morpholine-2-carboxamide 

Relevant articles and documents

Substituted Imidazopyridinyl-Aminopyridine Compounds

The present invention relates to substituted imidazopyridinyl-aminopyridine compounds and methods of synthesizing these compounds. The present invention also relates to pharmaceutical compositions containing substituted imidazopyridinyl-aminopyridine compounds and methods of treating cell proliferative disorders, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.